Editorial response: Treatment of cystic echinococcosis--improving but still limited.
Schantz
P M
PM
D015766:Albendazole / Q000009:adverse effects / Q000627:therapeutic use*; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D004443:Echinococcosis / Q000188:drug therapy* / Q000473:pathology; D004444:Echinococcosis, Hepatic / Q000188:drug therapy* / Q000473:pathology; D004445:Echinococcosis, Pulmonary / Q000188:drug therapy* / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D008463:Mebendazole / Q000009:adverse effects / Q000627:therapeutic use*
D000871:Anthelmintics; D008463:Mebendazole; D015766:Albendazole